Nasal insert and cannula and methods for the use thereof

Information

  • Patent Grant
  • 10716700
  • Patent Number
    10,716,700
  • Date Filed
    Thursday, July 20, 2017
    7 years ago
  • Date Issued
    Tuesday, July 21, 2020
    4 years ago
Abstract
A nasal insert includes a housing having a circumferential wall defining an interior passage. The wall has a longitudinal gap extending along a length thereof, with an outer peripheral dimension of the housing being adjustable by varying the gap. A valve is in communication with the interior passage and limits a fluid flow through the interior passage in at least one direction. In another embodiment, a nasal insert includes a user interface having a tubular housing defining an interior cavity open at opposite ends. An exterior surface of the housing is adapted to interface with a nasal vestibule of a user. A base is received in the interior cavity of the housing and includes an exit port. A cap is connected to the base and has an input port. A valve member is disposed in an interior passage defined by at least one of the cap and base, with the valve member being moveably received in the interior passage. Methods of using and assembling the nasal inserts also are provided.
Description
TECHNICAL FIELD

The present invention relates generally to a nasal insert, and in particular, to a nasal insert and cannula suitable for the treatment of various sleep disorders, including without limitation sleep apnea.


BACKGROUND

There are a wide variety of different diseases and physiological disorders associated with breathing, including sleep disorders such as sleep apnea and snoring, chronic obstructive pulmonary disease (CPOD), bronchitis, asthma and others. Many of these diseases and disorders may be treated by modifying the respiratory cycle.


For example, various oral or dental devices, such as the mandibular advancement device (MAD), have been developed for sleep apnea, and may be effective for treatment of mild sleep apnea, especially for patients that sleep on their back or stomach, and may improve airflow for patients with severe sleep apnea. These types of oral/dental devices may not be as effective, however, as continuous positive airway pressure devices (CPAP). Moreover, oral/dental devices are typically expensive, and may be associated with various side effects, including nighttime pain, dry lips, tooth discomfort, rearrangement in tooth and jaw positions, and excessive salivation, one or more of which may lead to reduced patient compliance.


CPAP devices will effectively control sleep apnea, but patient compliance may again be low, due for example to the discomfort of, and claustrophobic feeling associated with, the mask, pressure of the device, noise associated with the machine, entanglement of tubes, etc.


Other devices, as disclosed for example and without limitation in U.S. Pat. No. 7,735,491 to Doshi, U.S. Pat. No. 6,626,179 to Pedley and WO 2007/134458 to Robitaille, have been developed to treat sleep apnea and other respiratory disease and disorders by interfacing with the nasal passage of the user. Many of these types of nasal insert devices, however, may be difficult to properly install and/or use, for example requiring screwing of the device into the nasal passageway. In other systems, a holdfast, which secures the device to the user, may be external to the user, leading to lower levels of comfort and compliance. Conversely, internal holdfast systems may have a limited size variance, leading to such devices being either too tight or too loose, and/or adversely affecting the comfort level of the device and the associated compliance. Indeed, internal holdfast systems are often intended to create a tight seal with the nasal passageway, which may limit the population associated with any particular device.


SUMMARY

Briefly stated, in one aspect, one embodiment of a nasal insert includes a housing having a circumferential wall defining an interior passage. The wall has a longitudinal gap extending along a length thereof, with an outer peripheral dimension of the housing being adjustable by varying the gap. A valve is in communication with the interior passage and limits a fluid flow through the interior passage in at least one direction.


In another embodiment, a nasal insert includes a user interface having a tubular housing defining an interior cavity open at opposite ends. An exterior surface of the housing is adapted to interface with a nasal vestibule of a user. A base is received in the interior cavity of the housing and includes an exit port. A cap is connected to the base and has an input port. A valve member is disposed in an interior passage defined by at least one of the cap and base, with the valve member being moveably received in the interior passage.


In yet another aspect, an embodiment of a nasal insert includes a housing including an interior passageway having a polygonal cross-section and a valve member disposed in the interior passageway. The valve member is moveably received in the interior passage and has a different cross-sectional shape than the polygonal cross-section. At least one airflow passageway is formed between the valve member and the interior passageway.


In another embodiment, a nasal insert includes a housing having a longitudinally extending flow passageway and an opening formed in a side thereof transversely to the flow passageway. A valve member is inserted into the flow passageway through the opening. A user interface is disposed around the housing and covers the opening so as to retain the valve member in the flow passageway. In one embodiment, a panel may be provided to cover the opening before the user interface is disposed around the housing.


Various methods of providing resistance during exhalation are also provided. For example, in one embodiment, a method of providing resistance during exhalation includes providing a housing having a circumferential wall defining an interior passage, wherein the wall has a longitudinal gap extending along a length thereof. The method includes squeezing the housing and thereby closing at least a portion of the gap, inserting the housing into a nasal passage of a user while the housing is being squeezed and releasing the housing and thereby letting the gap increase as the housing expands into the nasal passage of the user. The method further includes inhaling through the housing and passing air through a valve in communication with the interior passage and exhaling through the housing and limiting a flow of exhaled air through the interior passage with the valve while passing at least a portion of the exhaled air through the gap.


In another embodiment, a method of providing resistance during exhalation includes compressing a user interface having an exterior tubular housing, inserting the user interface into a nasal passage of a user while the user interface is being compressed, and releasing the user interface and thereby letting the user interface expand into the nasal passage of the user. The method further includes inhaling through an interior housing disposed in the exterior tubular housing, wherein the interior housing is less compressible than the exterior housing and passing air through a valve disposed in the interior housing. The method further includes exhaling through the interior housing and limiting a flow of exhaled air through the interior housing with the valve.


In another aspect, a method of assembling a nasal insert includes inserting a valve member through an opening in the side of a housing, wherein the housing has a longitudinally extending flow passageway, and disposing a user interface around the housing and thereby covering the opening with the user interface so as to retain the valve member in the flow passageway.


The various aspects and embodiments provide significant advantages over other nasal inserts. For example and without limitation, a nasal insert configured with a gap may be easily inserted into a wide population of users with different size nasal passageways. At the same time, the gap provides a defined passageway for the flow of air. In addition, an embodiment configured with a base and cap allows for secure disposal of the valve member, thereby avoiding aspiration into the user's lungs, while providing for a simple and robust design. At the same time, the interface between the valve member and passageway provides for predetermined air flow paths and associated amounts of resistance.


The present invention, together with further objects and advantages, will be best understood by reference to the following detailed description taken in conjunction with the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of a first embodiment of a nasal insert assembly.



FIG. 2 is a top view of the nasal insert shown in FIG. 1.



FIG. 3 is an end view of the nasal insert shown in FIG. 1.



FIG. 4 is an exploded perspective view of the nasal insert shown in FIG. 1.



FIG. 5 is a cross-sectional view of the nasal insert taken along line 5-5 of FIG. 3 during inhalation.



FIG. 6 is a cross-sectional view of the nasal insert taken along line 6-6 of FIG. 3 during exhalation.



FIG. 7 is an end view of one of the nasal inserts.



FIG. 8 is an enlarged partial cross-sectional view of the nasal insert taken along line 8 of FIG. 6.



FIG. 9 is an enlarged partial view taken along line 9 of FIG. 7.



FIG. 10 is a front view of a nasal cannula assembly.



FIG. 11 is a cross-sectional view taken along line 11-11 of FIG. 10.



FIG. 12 is an alternative embodiment of nasal insert assembly.



FIG. 13 is a side view of the nasal insert assembly shown in FIG. 12.



FIG. 14 is a perspective view of an alternative embodiment of a nasal cannula assembly.



FIG. 15 is a perspective view of an alternative embodiment of a nasal insert.



FIG. 16 is a side view of the nasal insert shown in FIG. 15.



FIG. 17 is an end view of the nasal insert shown in FIG. 15.



FIG. 18 is a cross-sectional view of the nasal insert shown in FIG. 15 during inhalation.



FIG. 19 is a cross-sectional view of the nasal insert shown in FIG. 15 during exhalation.



FIG. 20 is a cross-sectional view of an alternative embodiment of a nasal insert assembly.



FIG. 21 is an end view of the nasal insert assembly shown in FIG. 20.



FIG. 22 is a side view of the nasal insert assembly shown in FIG. 20.



FIG. 23 is a cross-sectional view of a nasal insert taken along line 23-23 of FIG. 22.



FIG. 24 is a cross-sectional view of a nasal insert.



FIG. 25 is an exploded view of one embodiment of a nasal insert.



FIG. 26 is a cross-sectional view of the nasal insert shown in FIG. 24 during inhalation.



FIG. 27 is a cross-sectional view of the nasal insert shown in FIG. 24 during exhalation.



FIG. 28 is a perspective view of an alternative embodiment of a nasal insert.



FIG. 29 is a first side view of the nasal insert shown in FIG. 28.



FIG. 30 is a second side view of the nasal insert shown in FIG. 28.



FIG. 31 is a cross-sectional view of the nasal insert taken along line 31-31 of FIG. 29.



FIG. 32 is an exploded view of the nasal insert shown in FIG. 28.



FIGS. 33A-C are three perspective views of the nasal insert shown in FIG. 28.



FIG. 34 is a perspective view of an alternative embodiment of a nasal insert assembly.



FIG. 35 is a top view of the nasal insert assembly shown in FIG. 34



FIG. 36 is a side view of the nasal insert assembly shown in FIG. 34.



FIG. 37 is a cross-sectional view of the nasal insert assembly taken along line 37-37 of FIG. 36.



FIG. 38 is a perspective view of the nasal insert assembly shown in FIG. 34 during inhalation.



FIG. 39 is a perspective view of the nasal insert assembly shown in FIG. 34 during exhalation.



FIG. 40 is a perspective view of an alternative embodiment of a nasal insert.



FIG. 41 is a side view of the nasal insert shown in FIG. 40.



FIG. 42 is an end view of the nasal insert shown in FIG. 40.



FIG. 43 is a cross-sectional view of a nasal insert taken along line 43-43 of FIG. 41.



FIG. 44 is a side view of the nasal insert shown in FIG. 40 during extraction.



FIG. 45 is a perspective view of the nasal insert shown in FIG. 40 during inhalation.



FIG. 46 is a perspective view of the nasal insert shown in FIG. 40 during exhalation.



FIG. 47 is a perspective view of a nasal cannula assembly.



FIG. 48 is a perspective view of a nasal insert assembly during inhalation.



FIG. 49 is a perspective view of a nasal insert assembly during exhalation.



FIG. 50 is a perspective view of an alternative embodiment of a nasal insert.



FIG. 51 is a side view of the nasal insert shown in FIG. 50.



FIG. 52 is a cross-sectional view of a nasal insert taken along line 52-52 of FIG. 51.



FIG. 53 is a cross-sectional view of alternative embodiment of a nasal insert during inhalation.



FIG. 54 is a perspective view of an alternative embodiment of a nasal insert assembly.



FIG. 55 is an end view of the nasal insert assembly shown in FIG. 54.



FIG. 56 is a top view of the nasal insert assembly shown in FIG. 55.



FIG. 57 is a perspective view of an insertion/extraction device.



FIG. 58 is an enlarged end view of the insertion/extraction device shown in FIG. 57.



FIG. 59 is a side view of the insertion/extraction device shown in FIG. 57.



FIG. 60 is a front view of the insertion/extraction device shown in FIG. 57.



FIG. 61 is a cross-sectional view of the insertion/extraction device shown in FIG. 57 taken along line 61-61.



FIG. 62 is a perspective view of the insertion/extraction device prior to engagement with a nasal insert.



FIG. 63 is a perspective view of the insertion/extraction device disposed relative to a nasal insert for engagement therewith.



FIG. 64 is a perspective view of the insertion/extraction device engaged with a nasal insert.



FIG. 65 is a front view of a nasal insert assembly applied to a user.



FIG. 66 is a perspective view of an alternative embodiment of a nasal insert assembly.



FIG. 67 is a top view of the nasal insert assembly shown in FIG. 66.



FIG. 68 is an end view of the nasal insert assembly shown in FIG. 66.



FIG. 69 is an side view of the nasal insert assembly shown in FIG. 66.





DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS

Referring to the drawings, various nasal inserts, nasal insert assemblies and nasal cannula assemblies are shown. The phrase “nasal insert” and “nasal insert assembly” refer to a nasal insert configured to interface with one or both nasal cavities of the user, or in a cavity formed in the user's tracheotomy. The phrase “nasal cannula” of “nasal cannula assembly” refers to a nasal insert or assembly coupled to a delivery tube configured to deliver oxygen or other gases.


The terms “longitudinal” and “axial” as used herein relates to a length or lengthwise direction, including for example generally the direction of flow of fluids through the nasal inserts and assemblies. The term “lateral” and variations thereof refer to a sideways direction. The terms “top” and “bottom” are intended to indicate directions when viewing the nasal insert when positioned for insertion into the nasal cavity of the user, with the “top” end thereof being inserted first. However, it should be understood that a user can use the nasal insert and assembly, and cannula assembly, when the user is in any number of positions, including but not limited to an upright position (seated or standing) or horizontal position (whether lying sideways, prone or supine).


It should be understood that the term “plurality,” as used herein, means two or more. The term “coupled” means connected to or engaged with, whether directly or indirectly, for example with an intervening member, and does not require the engagement to be fixed or permanent, although it may be fixed or permanent. The term “transverse” means extending across an axis, including without limitation substantially perpendicular to an axis. It should be understood that the use of numerical terms “first,” “second,” “third,” etc., as used herein does not refer to any particular sequence or order of components; for example “first” and “second” housing members may refer to any sequence of such members, and is not limited to the first and second indicator members of a particular configuration unless otherwise specified. It should be understood that the terms “input port” and “exit port” refer to the function of the ports during an inhalation phase, and that those same ports serve the opposite function (input and exit) during an exhalation phase.


Referring to FIGS. 1-9, one embodiment of a nasal insert 2 is shown as including a user interface 4 comprising a tubular housing defining an interior cavity 6 open at opposite ends. The user interface 4 has an exterior surface 8 adapted to interface with a nasal vestibule of a user. In one embodiment, the nasal insert is made of a compressible material, such as foam, and includes a plurality of annular ribs 10 as shown in FIGS. 1 and 2. The ribs may be more easily compressed and/or deflected, such that the nasal tissue is allowed to settle in between the ridges/ribs and help to maintain the nasal insert in the nasal cavity. Alternatively as shown in FIG. 4, the user interface 4 has a smooth and continuous exterior surface 8, with the interface 4 being compressed and then expanding against the walls of the nasal cavity to maintain the position of the nasal insert in the cavity.


The nasal insert 2 may be configured as a single unit, which is suitable for independent and separate insertion into a single nasal cavity of the user or tracheomoty, or may include a pair of units, connected with a bridge 12, which are configured for insertion into adjacent nasal cavities of the user as shown for example in FIG. 65. It should be understood that other embodiments described and shown herein may be inserted, or installed, in a similar manner. In various embodiments, the bridge 12 may be configured as a resilient strap in a U-shape, such that it does not interfere with the user's nose. The bridge 12 may be grasped for inserting and extracting the nasal inserts 2 from the nasal cavities. In other embodiments, the bridge may be configured as a tether.


The nasal insert 2 further includes a base 50 that is shaped to be received in the interior cavity 6 of the user interface housing. The base 50 defines and includes an exit port 52. A cap 24 is connected to the base and defines and includes an input port 54. The base and cap are configured to fit together, with one or both of the base and cap, alone or in combination, defining an interior passageway 40. A valve member 30 is moveably disposed in the interior passage. As shown in FIG. 5, the bridge 12 may be formed integrally with the base 50, or alternatively with cap 24, with the base or bridge having a catch or tab 14 that is received in a groove or recess 16 formed on an interior of the user interface housing 4 so as to secure and prevent relative longitudinal movement of the cap/base and user interface.


As shown in FIGS. 4-6, an insert end 18 of the base narrows, whether by tapering or curvature, relative to an opposite end 20 secured to the cap 24, so as to form a neck. In this way, the user interface 4, which fits as a collar around the neck, may be compressed to a greater degree at the insert end. Preferably, the base is made of a less compressible material than the user interface. The various components may be made of medical grade plastics appropriate for the different application and which are approved by the FDA. For example, the base may be made from a variety of engineering thermoplastics including without limitation polycarbonate, polyphenylene, polyethylene or polypropylene. The user interface may be made of rubber, foam or the like, or combinations thereof, including without limitation low density polymers, polyurethane elastomers or synthetic silicone. The insert end 18 of the base may be configured with a rim 22, which engages and retains the user interface 4 around the base.


In one embodiment, the cap 24 includes a baffle 26 defining a plurality of valve openings 28, shown as three, arranged around a central opening 36. It should be understood that the baffle may be formed on the base, or separately formed and coupled between the base and cap. In one embodiment, best shown in FIGS. 7-9, the valve openings 28 have substantially a kidney bean shape, with an interior edge 29 being substantially linear or with a slight curve or large radius. In this way, the valve member 30, which abuts against the baffle (acting as a valve seat), is prevented from closing entirely the valve openings during exhalation, thereby providing a bleed opening 32 that provides continuous resistance to the exhaled air flow, which creates in turn a positive pressure in the airways to prevent airway tissue from obstructing the breathing passageway of the user. For example, the back of the tongue muscle may rest against the soft palate, and both against the oral pharynx. In another example, when the patient is lying on their back and asleep, the side walls may fall together to narrow or close the airway. When the muscles of breathing work to expand the chest and lower the diaphragm to draw in a breath of air, a negative pressure is generated that literally sucks the tissue together. The positive pressure in the airway created by the nasal insert assembly during exhalation prevents the tissues from making contact and being sucked together during inhalation. Instead, the tissues expand away from each other, with the apnea and snoring thereby being greatly reduced. At the same time, the bleed openings 32 provide for an escape passageway for oxygen when the nasal insert is coupled to a gas supply in a nasal cannula configuration, as further explained below. The bleed passageways also create a safety feature that provides a constant leak during exhalation.


In one embodiment, the valve member 30 is configured as an O-ring, which moves reciprocally in the passageway 40 defined by the cap 24 and base 50. In one embodiment, the valve member surrounds and is moveable along a hub 48, which is configured with three fingers in one embodiment and forms part of the baffle 26. The three fingers help control and maintain the alignment of the O-ring valve member along a centerline of the assembly. In an inspiration position, shown in FIG. 5, the valve member 30 is abutted against a stop 42, but does not seal against the stop, such that gas, including for example and without limitation air, may flow freely to the user through the exit port 52 during inhalation. In addition, the central passageway 36 is formed through the hub 48 defining the baffle. The central passageway 36 remains open at all times during both inhalation and exhalation. In one embodiment, the central opening 36 has a diameter of about 1 mm, while in other embodiments, the opening may have a diameter of 1.2 mm to 1.6 mm. During inhalation, due to the central passageway 36 and the openings 28, which are not blocked by the valve member, less than or about 1 cm of water resistance is generated during inhalation.


During exhalation as shown in FIGS. 6-9, the valve member 30 moves toward the seat 26 and partially closes or blocks the openings 28 leaving only the bleed openings 32 uncovered, together with the central passageway 36, thereby creating a positive pressure within the airways of about 5 to 20 cm. of water, and in one embodiment between about 5 and 15 cm.


The cap 24 and base 50 are coupled together, for example with a snap fit. As shown in FIGS. 4 and 15-19, the base may have a pair of resilient arms 58 that interface and slide along a pair of recesses 60 until the arms are engaged with the cap by way of a snap fit, with the base having an outer annular skirt 62 overlapping an inner annular skirt 64 of the cap. Of course, the overlap may be reversed. The user interface is then disposed over one or both of the cap and base, and may further secure, or maintain the coupling between, those components one to the other. The user interface 4 may be secured by way of friction, or with adhesives or other fasteners such as the tab 14 and recess 16 interface or rim 22.


Referring to the embodiment of FIGS. 10 and 11, the nasal insert may be coupled to a cannula 70 so as to deliver a gas such as oxygen. In this embodiment, the cap includes an insert portion or prong 72 defining a central opening 74 therethrough, which opening 74 is in fluid communication with the central opening 36 passageway of the baffle. The prong 72 extends outwardly from the cap 24 and has an exterior surface 80 with a shape, such as a tapered frusto-conical shape or a tubular shape, configured to be received in an inlet tube 76 of the nasal cannula, which further communicates with a manifold tube 86. A supply tube 90, or a pair thereof, may then be coupled to opposite ends of the manifold. Conversely, the insert portion 72 may have an inner diameter sized and shaped to receive the inlet tube 76. In either embodiment, an opening 92 is formed around the outside of the tube and insert such that ambient air may also be inhaled through the nasal insert. In this way, a continuous flow of oxygen during inhalation and exhalation may be maintained without any restriction to the oxygen gas flow.


In an alternative embodiment, shown in FIGS. 12-14, the bridge also serves as a clip having a pair of resilient arms 100 with curved clamping members 102, which may be secured to a cannula. Again, the nasal insert may be configured with an insert portion. The clip may be in-molded with the base, or separately configured and attached to the base and/or cap. The arms 100 may be biased away from each other as a manifold 88 is inserted between the clamping members 102, with the arms 100 then being released to secure the nasal insert to the manifold.


In an alternative embodiment, shown in FIGS. 20-24, a valve member 130 is configured as a ball. In this embodiment, a housing 131 defines the interior passageway 132, which is configured with a polygonal cross-section, including for example and without limitation as a triangle, rectangle (including square), diamond, hexagon, pentagon, octagon, etc. In this way, the ball shaped valve member 130 is not allowed to completely seal the passageway 132 as air flows around the ball at the corners of the adjoining walls defining the interior cross-section of the passageway. The housing 131 may be may a single piece, or may be configured with a base and cap. At an outlet end 134 to the passageway, there is a minimal amount of resistance during inhalation due to the configuration of the valve seat 136 interfacing with the valve member, with the valve seat including a plurality of stops 144. At the inlet end 138, a circular opening 140 is presented in the passageway. The ball shaped valve ember 130 is prevented from closing the opening in the passageway by a plurality of bars or stops 142 which define a valve seat. The length of the stops 142 determines the resistance of air flow by setting the distance between the ball 130 and the circular opening 140. The less space, the greater the resistance and an associated pressure in the upper airways of the user.


Referring to FIGS. 20-27, the outlet end 134 may have more substantial stops 144 or indents that prevent the ball from sealing the passageway, and thereby allow for minimum resistance to air flow. At the inlet end 138, the stops 142 are shorter, or have a lesser extent, such that the ball 130 may move closer to the opening 140 and thereby create a greater resistance, and higher pressures in the upper airways during exhalation. In one embodiment, the stops 144 are permanently fixed at the outlet end, while at the inlet end the length or amount of protrusion of the stops 142 may be variable, for example by screwing a valve seat longitudinally in or out, by moving the valve seat against the force of friction, by fixing the position thereof with detents, or by rotating the stops 142 with a ratchet type device or other tool. In this way, the valve member 130 moves reciprocally in opposite first and second directions I and E in response to the flow inhalation and exhalation flows If and Ef in response to inhalation and exhalation by a user, with the valve member engaging a first valve seat 144 when moved in the first direction in response to the user inhalation, and wherein the valve member engages a second valve seat 142 when moved in the second direction in response to the user exhalation. The first and second valve seats 144, 142 are configured such that the valve member 130 creates a greater resistance to air flow during the user exhalation than during the user inhalation.


Referring to FIG. 24, a single insert may be used for a tracheotomy and/or an endotracheal tube. The openings at the opposite ends of the passageway may be about 15 mm. In one embodiment, the an outside diameter at the outlet opening is 15 mm OD, while the cap has an inlet opening with a 15 mm inner diameter, such that the assembly may be coupled to an endotracheal tube or tracheotomy tube. In some embodiments, the openings at the opposite ends of the passageway may be about 8 mm to about 10 mm in diameter.


In one embodiment, shown in FIGS. 24-27, a housing 150 is formed as a single homogenous unit defining a longitudinal passageway 152, with an access opening 154 formed in a side of a housing transverse to the passageway. A panel 156, shown as a hinged door, may be moved from an open to a closed position. During assembly, the panel 156 is opened and the valve member 130, shown as a ball, is inserted transversely through the access opening 154. The panel 156 is then closed, with the user interface 4 then being disposed over the housing 150 to secure the panel in place. The valve member 130 reciprocally moves in a longitudinal direction within the passageway 152. Again, stops 142, 144 may be positioned at opposite ends of the passageway adjacent the openings 140 to provide a differential resistance upon inhalation and exhalation. In one embodiment, the stop at the inlet end may be fixed or varied between 0.01 mm to about 2 mm, or between about 0.01 mm to about 1.5 mm in other embodiments. The lesser the height, the greater the resistance to exhaled gases, and the greater the corresponding positive pressure achieved in the user's upper airway passage.


Referring to the embodiment shown in FIGS. 28-33C, a shorter insert 190, suitable for a user having smaller vestibule openings, is shown as including a base 200 with an elongated strap 202. During assembly, a valve member 130 is disposed in a cavity 204 formed in the end of the base. A cap member 206 is then secured to the base to trap or hold the valve member in an interior passageway, defined by the cavity 204. The strap 202 is then bent or curved around, such that a free end portion 208 thereof maybe secured to the base, for example by engaging a button 212 with a hole 210 in the end portion. It should be understood that any form of coupling, including a loop/insert, snap fit, adhesives, mechanical fasteners, etc. may also be suitable. A user interface 240 is then disposed over the base, and covers the free end of the strap to complete the assembly. The user interface has a plurality of exterior, longitudinally extending recesses 242, which form and define air vents, and also function as an interference fit with the nasal tissues. In this way, the strap provides a grippable handle 220 suitable for assisting in inserting and extracting the nasal insert into and out of the nasal cavity of the user. The cap 206 and base 200 may again be configured with stop members 142, 144 at each end of the passageway to provide predetermined resistances during inhalation and exhalation.


Referring to FIGS. 57-64, an insertion/extraction device 500 is shown. The insertion/extraction device maybe configured with an elongated handle 502 that can be gripped by a user or caregiver. One end of the handle is configured with a pair of spaced apart hooks 504, 506 defining a gap 508, with each hook having a curved portion forming a recess or groove 510, 512. The grooves 510, 512 open in the opposite direction. An opposite end of the handle is configured with a magnet 520. The end of the handle includes a housing 514 with slits 516. The housing defines a cavity. The slits 516 permit the housing walls to be expanded for insertion of the magnet 520. The housing further includes an end cover 522, with slits, configured as a lip or rim in one embodiment, which encapsulate the magnet. The cover is thin enough so as to allow a sufficient magnetic force to attract a metal component disposed on or in an adjacent, corresponding nasal insert.


In operation, and referring to FIGS. 63 and 64, the insertion/extraction device 500 can be used to insert and extract the various nasal inserts described herein. For example and without limitation, the handle 502 can be moved toward an insert 190 having a strap 202, with the strap disposed in the gap 508 between the hooks 504, 506. The handle 502 is then rotated about a longitudinal axis 530 such that the hooks 504, 506 engage the strap in their respective grooves 510, 512 as shown in FIG. 64. The handle 502 may then be manipulated to insert the nasal insert 190 into the vestibule. The handle 502 and nasal insert 290 may be rotated (e.g., counterclockwise) such that the nasal insert resides in a comfortable position in the vestibule. The handle 502 may then be rotated in the opposite direction (e.g., clockwise) so as to disengage the hooks 504, 506 from the strap 202, with the handle 502 then being moved away from the nasal insert 190. The insertion/extraction device may also be used to extract the nasal insert by engaging the strap 202 through rotation and then moving the handle 502 and connected nasal insert 190 away from the vestibule to effect an extraction.


The opposite end of the handle may also be used for insertion/extraction. For example, the magnet 520 may attract a nasal insert, which may then be manipulated and inserted into a vestibule. The handle 502 may then be twisted or turned to disengage the magnet 520. The nasal insert may be extracted by first engaging the handle 502 through a magnetic attraction with the nasal insert, with the handle 520 and insert then being moved away from the vestibule.


Referring to FIGS. 34-56, a nasal insert includes a housing 300, 400 comprising a circumferential wall defining an interior passage. In one embodiment, the insert is formed with a generally spherical shape having a diameter of from about 8 mm to about 16 mm, and in one embodiment from about 12 mm to about 16 mm. The housing may be made low density polymers. The wall is configured with a longitudinal gap 304, 404 or slit that extends along a length thereof, and thereby communicates between the interior passageway 312, 412 and an exterior of the housing. In one embodiment, the gap is less than about 0.5 mm wide. In other embodiments, the slit is between about 2 mm and 4 mm. The housing 300, 400 may be gripped and squeezed such that an outer peripheral dimension of the housing, measured about a cross-section of the housing in a plane perpendicular to a longitudinal axis, is adjustable by varying the gap 304. In this way, the open side wall of the insert allow for adjustment of the size of the housing such that the housing will fit in different size nasal vestibules.


A valve 306 is in communication with the interior passage 312. The valve 306 limits a fluid flow through the interior passage in at least one direction. In one embodiment, the valve 306 is configured as a hinged flap covering one end of the interior passage. As shown in FIGS. 34-39 and 53-55, the valve flap 306, 406 covers the inlet end 316 of the passageway, such that the 306 flap may open during inhalation and close during exhalation. During inhalation, the flap 306 opens and allow for gases to be inhaled with minimum resistance, with an opening having a diameter of about 5 to 5.4 mm, and in another embodiment about 1.2 mm. During exhalation, the flap 306 closes and the expired gases pass around the flap along the gap 304 through an exhalation opening 314, which creates resistance and back pressure in the upper airway passage of the user. The flap 306 and gap 304 form a small bleed opening 308 positioned just below the flap 306. The opening may be between about 0.3 mm and 0.5 mm, with the area about 1 mm2 to about 2 mm2.


As shown in FIGS. 34-39, 48, 49 and 53-56, a bridge member 310 may connect a pair of nasal inserts at an end thereof opposite the hinged flap, with the bridge forming a grippable handle that facilitates insertion and extraction of the inserts. The bridge may include, or be made of a metal or hard plastic insert, which provides stability for the housing. The bridge may also be configured with a cannula clip as described above. The housing may have a substantially spherically shaped exterior, a frusto-conically shaped exterior, a cylindrically shaped exterior, or be otherwise shaped to interface with the nasal vestibule of the user. In one embodiment, a spherically shaped housing has an exterior surface with a radius of about 8 mm. In these embodiments, the flap 306 is substantially round.


Referring to FIGS. 40-47 and 50-52, a nasal insert housing 400 is further configured with a grippable handle 402 hingedly attached to the housing at an end thereof opposite the hinged flap 406. In one embodiment, the handle has an opening 420 therethrough, such that the handle is shaped to receive a cannula tube or port/nipples as shown in FIG. 47. In this way, the insert does not interfere with the flow of oxygen at any time during use. Indeed, the resistance to exhaled gases will improve the oxygen saturation by not allowing the alveoli to collapse. The handle 402 is pivotally attached to the housing such that it may be gripped and pivoted outward away from the user to thereby extract the insert. The handle 402 may snap into either or both of the open and closed positions. Preferably, the insert is disposed entirely inside the nasal cavity, or vestibule, of the user during use, with the handle being moved to the closed position to avoid any protrusion of the insert outside of the vestibule. The handle, whether configured as a single insert embodiment or a bridge, may be magnetized, or made of metal, or include a metal insert 413 as shown in FIG. 52, that will be attracted by a magnet, such that a magnet or metal tool may be used to insert and extract the device. In addition, or alternatively, the handles may be configured with a filter material across the opening 420, such that the handles act as filters when closed. The handles may also be configured as a humidity moisture exchanger or medication holder.


Referring to the embodiments of FIGS. 40-52, whether configured as a pair of inserts connected with a bridge 310 or as separate units configured with a handle 402, a plurality of longitudinally extending recesses 442, or leak passageways, are defined on the exterior surface of the housing 400 and provide for some leakage of gas flow as well as provide for better retention of the housing as corresponding ribs grip the interior nasal tissue, with the tissue deforming into the recesses. The recesses may have a width of between about 0.1 and 1.6 mm, and in one embodiment between about 0.6 mm and 1.6 mm. The various devices may create a constant back pressure during exhalation in the range of about 5 to 20 cm of water, while the resistance is less than about 2 cm of water during inhalation.


In various embodiments, especially where configured as a single insert without a bridge providing stability, one or more interior, annular ribs 432, shown as three in one embodiment (FIGS. 41 and 43) or as one in another embodiment (FIGS. 51-52), may be spaced along the longitudinal axis 411 and lie in planes substantially perpendicular thereto. The ribs help maintain the overall shape of the insert and bias the insert against the nasal tissue. In one embodiment, undercuts defining the ribs are about 1.2 mm wide with a maximum depth of about 0.5 mm. The nasal insert includes a gap 404 and an interior passageway 412, with the user squeezing the insert to vary the gap 404 as the insert is inserted and/or extracted. Again, a leak or bleed opening 408 may be formed between the valve flap 406 and the gap 404 as shown in FIGS. 46 and 49.


The use of separate inserts may be particularly advantageous for users that, due to anatomical structure or nasal injury, use only one nostril for inhalation/exhalation. In addition, some users may have different internal heights in the vestibule area, thereby allowing the user to customize the individual insert to be used in each nasal cavity.


Referring to FIGS. 66-69, a nasal insert assembly 600 includes a pair of nasal inserts 602. In one embodiment, the inserts are spaced about 18 mm center to center, and have a length of about 11 mm. Each nasal insert has a user interface formed in a molded cup shape having a plurality of (shown as four) tongue-shaped petals or flaps 604 defining a curved, or conoid shaped insert portion. Although shown as four flaps, it should be understood that a greater or lesser number may also be suitable. It should be understood that the term conoid includes and refers to an outer surface portion of a sphere, cone, various spheroids, catenoids and/or paraboloids, and includes various convexly curved surfaces. The flaps 604 are separated by slits 606 formed in the insert, with one more end portions of the flaps moveable to form and opening in response to an inhalation flow, and then with the end portions closing against each other during exhalation or when at rest. The ends of the flaps may be trimmed in one embodiment, for example with a concavely curved recess, so to form a small opening 608 in the end of each insert. In one embodiment the opening 608 has a radius of about 1 mm. Alternatively, the opening may be omitted. An annular wall 610 is formed below the slits. In one embodiment, the annular wall 610 has a height of about 12 mm, and a width of about 11 mm. A spiral rib 612 is formed on the outer surface of the annular wall 610. As shown, a pair of inserts are connected with a bridge 310 made, for example, of silicone or a flexible like material, such that the assembly may be molded as a one piece molded unit. There are no additional pieces, such as an internal valve, required to make this nasal insert function.


Each insert 602 has an inlet port opening into an interior space. One or more of the flaps 604 will open to allow inhaled air to flow from the interior space to the patient's lungs. There is very little resistance, e.g., less than 2 cm of water, during inhalation. Upon exhalation, the flaps 604 are closed such that the exhaled air is directed along the outer surface of the flaps. The air travels down a circular, spiral flow path 616 defined by and between the spiral rib 612 and the nasal vestibule tissue engaged therewith, which creates a tortuous flow path for the exhaled air. The tortuous flow path produces a resistance to exhaled air flow which in turn creates an increased air pressure in the patient's respiratory system. The increase in pressure will be in the range between 5 and 20 cm of water. The spiral rib 612 may also be easily compressed such that the nasal tissue is partially allowed to settle in between the spiral rib and help maintain the nasal insert in the nasal cavity.


Although the present invention has been described with reference to preferred embodiments, those skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention. As such, it is intended that the foregoing detailed description be regarded as illustrative rather than limiting and that it is the appended claims, including all equivalents thereof, which are intended to define the scope of the invention.

Claims
  • 1. A nasal insert comprising: a housing comprising a circumferential wall defining an interior passage, wherein said wall comprises a longitudinal gap extending along a length thereof, wherein an outer peripheral dimension of said housing is adjustable by varying said gap; anda valve in communication with said interior passage, said valve limiting a fluid flow through said interior passage in at least one direction wherein said wall comprises an exterior surface defining a leak passageway, wherein said leak passageway comprises a longitudinally extending recess parallel to said gap.
  • 2. The nasal insert of claim 1 wherein said valve comprises a hinged flap covering one end of said interior passage.
  • 3. The nasal insert of claim 2 further comprising a grippable handle coupled to said housing opposite said hinged flap.
  • 4. The nasal insert of claim 3 wherein said handle comprises an opening therethrough shaped to receive a cannula port.
  • 5. The nasal insert of claim 4 wherein said handle is pivotally attached to said housing.
  • 6. The nasal insert of claim 1 comprising a pair of said housings coupled respectively to a pair of said valves, with a bridge connecting said pair of housings.
  • 7. The nasal insert of claim 1 wherein said housing comprises at least one rib formed around at least a portion of said interior passage.
  • 8. The nasal insert of claim 7 wherein said at least one rib comprises an annular rib.
  • 9. The nasal insert of claim 1 wherein said housing comprises a substantially spherical outer surface.
  • 10. The nasal insert of claim 1 wherein said housing comprises a substantially cylindrical outer surface.
  • 11. The nasal insert of claim 1 wherein said gap has a width of between about 2 mm and 4 mm.
  • 12. The nasal insert of claim 1 wherein said gap is singular.
  • 13. A method of providing resistance during exhalation comprising: providing a housing comprising a circumferential wall defining an interior passage defining a longitudinal flow path, wherein said wall comprises a longitudinal gap extending along a length thereof;squeezing said housing and thereby closing at least a portion of said gap;inserting said housing into a nasal passage of a user while said housing is being squeezed;releasing said housing and thereby letting said gap increase as said housing expands into said nasal passage of the user;inhaling through said housing and passing air through a valve in communication with said interior passage; andexhaling through said housing and limiting a flow of exhaled air through said interior passage with said valve and passing at least a portion of said exhaled air through said gap permitting a leakage a gas flow through a leak passageway defined between an exterior surface of said wall and said user's nasal tissue during said exhaling.
  • 14. The method of claim 13 wherein said valve comprises a hinged flap covering one end of said interior passage, wherein said passing air through said valve comprise opening said flap.
  • 15. The method of claim 13 wherein said leak passageway comprises a longitudinally extending recess formed in said exterior surface parallel to said gap.
  • 16. The method of claim 13 further comprising creating a constant back pressure during exhalation in a range of about 5 to 20 cm H2O.
  • 17. The method of claim 13 wherein said gap is singular.
Parent Case Info

This application is a continuation of U.S. application Ser. No. 13/629,921, filed Sep. 28, 2012, which claims the benefit of U.S. Provisional Application No. 61/540,740, filed Sep. 29, 2011, entitled “Nasal Insert and Cannula and Methods for the Use Thereof,” the entire disclosures of which are hereby incorporated herein by reference.

US Referenced Citations (229)
Number Name Date Kind
628111 McHatton Jul 1899 A
669098 Overshiner Mar 1901 A
675275 Gunning May 1901 A
746869 Moulton Dec 1903 A
774446 Moulton Nov 1904 A
810617 Carence Jan 1906 A
1819884 Fores Aug 1931 A
1867478 Stelzner Jul 1932 A
2198959 Clarke Apr 1940 A
2237954 Wilson Apr 1941 A
2264153 Rowe Nov 1941 A
2274886 Carroll Mar 1942 A
2282681 Stotz May 1942 A
2335936 Hanlon Dec 1943 A
2433565 Korman Dec 1947 A
2448724 McGovney Sep 1948 A
2672138 Carlock Mar 1954 A
2751906 Irvine Jun 1956 A
2777442 Zelano Jan 1957 A
3145711 Beber Aug 1964 A
3370305 Goott et al. Feb 1968 A
3424152 Kuhlman Jan 1969 A
3451392 Cook et al. Jun 1969 A
3463149 Albu Aug 1969 A
3513839 Vacante May 1970 A
3556122 Laerdal Jan 1971 A
3695265 Brevik Oct 1972 A
3710799 Caballero Jan 1973 A
3722509 Nebel Mar 1973 A
3747597 Olivera Jul 1973 A
3884223 Keindl May 1975 A
3902621 Hidding Sep 1975 A
4004584 Geaney Jan 1977 A
4030491 Mattila Jun 1977 A
4040428 Clifford Aug 1977 A
4054134 Kritzer Oct 1977 A
4062358 Kritzer Dec 1977 A
4120299 Russo Oct 1978 A
4143872 Havstad et al. Mar 1979 A
4226233 Kritzer Oct 1980 A
4240420 Riaboy Dec 1980 A
4249527 Ko et al. Feb 1981 A
4267831 Aguilar May 1981 A
4325366 Tabor Apr 1982 A
4327719 Childers May 1982 A
RE31040 Possis Sep 1982 E
4354489 Riaboy Oct 1982 A
4403616 King Sep 1983 A
4456016 Nowacki et al. Jun 1984 A
4487207 Fitz Dec 1984 A
4533137 Sonne Aug 1985 A
4582058 Depel et al. Apr 1986 A
4601465 Roy Jul 1986 A
4739987 Nicholson Apr 1988 A
4822354 Elosegui Apr 1989 A
4854574 Larson et al. Aug 1989 A
4862903 Campbell Sep 1989 A
4878513 Ashby et al. Nov 1989 A
4908028 Colon et al. Mar 1990 A
4944310 Sullivan Jul 1990 A
4973047 Norell Nov 1990 A
4979505 Cox Dec 1990 A
4984302 Lincoln Jan 1991 A
4984581 Stice Jan 1991 A
5033312 Stupecky Jul 1991 A
5038621 Stupecky Aug 1991 A
5059208 Coe Oct 1991 A
5078739 Martin Jan 1992 A
5092781 Casciotti et al. Mar 1992 A
5117820 Robitaille Jun 1992 A
5197980 Gorshkov et al. Mar 1993 A
5255687 McKenna Oct 1993 A
5383470 Kolbly Jan 1995 A
5385542 Rawlings Jan 1995 A
5391205 Knight Feb 1995 A
5392773 Bertrand Feb 1995 A
5394867 Swann Mar 1995 A
5415660 Campbell et al. May 1995 A
5425359 Liou Jun 1995 A
5459544 Emura Oct 1995 A
RE35339 Rapoport Oct 1996 E
5562641 Flomenblit et al. Oct 1996 A
5568808 Rimkus Oct 1996 A
5607469 Frey Mar 1997 A
5649533 Oren Jul 1997 A
5665104 Lee Sep 1997 A
5740798 McKinney Apr 1998 A
5743256 Jalowayski Apr 1998 A
5763979 Mukherjee et al. Jun 1998 A
5775335 Seal Jul 1998 A
5782896 Chen et al. Jul 1998 A
5797920 Kim Aug 1998 A
5816241 Cook Oct 1998 A
5865170 Moles Feb 1999 A
5876434 Flomenblit et al. Mar 1999 A
5890998 Hougen Apr 1999 A
5899832 Hougen May 1999 A
5910071 Hougen Jun 1999 A
5911756 Debry Jun 1999 A
5929286 Krumpelt et al. Jul 1999 A
5947119 Reznick Sep 1999 A
5954766 Zadno-Azizi et al. Sep 1999 A
5957978 Blom Sep 1999 A
5992006 Datsikas Nov 1999 A
6004342 Filis Dec 1999 A
6083141 Hougen Jul 2000 A
6110861 Krumpelt et al. Aug 2000 A
D430667 Rome Sep 2000 S
6119690 Pantaleo Sep 2000 A
6177482 Cinelli et al. Jan 2001 B1
6258100 Alferness et al. Jul 2001 B1
6287290 Perkins et al. Sep 2001 B1
6293951 Alferness et al. Sep 2001 B1
6369126 Cinelli et al. Apr 2002 B1
6386197 Miller May 2002 B1
6443944 Doshi et al. Sep 2002 B1
6484725 Chi Nov 2002 B1
6558831 Doshi et al. May 2003 B1
6561188 Ellis May 2003 B1
6562057 Santin May 2003 B2
6564800 Olivares May 2003 B1
6568387 Davenport et al. May 2003 B2
6585639 Kotmel et al. Jul 2003 B1
6592594 Rimbaugh et al. Jul 2003 B2
6595215 Wood Jul 2003 B2
6626172 Karow et al. Sep 2003 B1
6626179 Pedley Sep 2003 B1
6632554 Doshi et al. Oct 2003 B2
6679264 Deem et al. Jan 2004 B1
6722360 Doshi Apr 2004 B2
6756144 Issacci et al. Jun 2004 B2
6863066 Ogle Mar 2005 B2
6872439 Fearing et al. Mar 2005 B2
6921574 Cinelli et al. Jul 2005 B2
6997177 Wood Feb 2006 B2
7001684 Doshi et al. Feb 2006 B2
7011723 Full et al. Mar 2006 B2
7047969 Noble May 2006 B2
7156098 Dolezal et al. Jan 2007 B2
7156099 Jenkins Jan 2007 B1
7175723 Jones et al. Feb 2007 B2
7178524 Noble Feb 2007 B2
7201169 Wilkie et al. Apr 2007 B2
D542407 Stallard et al. May 2007 S
7211342 Issacci et al. May 2007 B2
7263996 Yung Ho Sep 2007 B2
7334581 Doshi Feb 2008 B2
7493902 White et al. Feb 2009 B2
7506649 Doshi et al. Mar 2009 B2
7615304 Ferrall et al. Nov 2009 B2
7658189 Davidson et al. Feb 2010 B2
7676276 Karell Mar 2010 B2
7678132 Abbott et al. Mar 2010 B2
7708017 Davidson et al. May 2010 B2
7735491 Doshi et al. Jun 2010 B2
7735492 Doshi et al. Jun 2010 B2
7775210 Schobel et al. Aug 2010 B2
7798148 Doshi et al. Sep 2010 B2
7806120 Loomas et al. Oct 2010 B2
7856979 Doshi et al. Dec 2010 B2
7987852 Doshi et al. Aug 2011 B2
8281557 Doshi et al. Oct 2012 B2
20010051799 Ingenito Dec 2001 A1
20010052344 Doshi Dec 2001 A1
20010056274 Perkins et al. Dec 2001 A1
20020062120 Perkins et al. May 2002 A1
20020177031 Doshi et al. Nov 2002 A1
20020177871 Santin Nov 2002 A1
20030004498 Doshi et al. Jan 2003 A1
20030054215 Doshi et al. Mar 2003 A1
20030106555 Tovey Jun 2003 A1
20030124401 Issacci et al. Jul 2003 A1
20030140925 Sapienza et al. Jul 2003 A1
20030154988 Devore et al. Aug 2003 A1
20030158515 Gonzalez et al. Aug 2003 A1
20030195552 Santin Oct 2003 A1
20030209247 O'Rourke Nov 2003 A1
20040016432 Genger et al. Jan 2004 A1
20040020493 Wood Feb 2004 A1
20040059368 Maryanka Mar 2004 A1
20040067235 Doshi Apr 2004 A1
20040141875 Doshi Jul 2004 A1
20040146773 Doshi et al. Jul 2004 A1
20040194779 Doshi Oct 2004 A1
20040194780 Doshi Oct 2004 A1
20040209134 Issacci et al. Oct 2004 A1
20040261791 Horian Dec 2004 A1
20050003262 Doshi Jan 2005 A1
20050011524 Thomlinson et al. Jan 2005 A1
20050051770 Ando et al. Mar 2005 A1
20050133026 Seleznev et al. Jun 2005 A1
20050284479 Schrader et al. Dec 2005 A1
20060032497 Doshi Feb 2006 A1
20060085027 Santin et al. Apr 2006 A1
20060096596 Occhialini et al. May 2006 A1
20060144398 Doshi et al. Jul 2006 A1
20060150978 Doshi et al. Jul 2006 A1
20060150979 Doshi et al. Jul 2006 A1
20060283461 Lubke et al. Dec 2006 A1
20070095349 Hansmann et al. May 2007 A1
20070175478 Brunst Aug 2007 A1
20070227542 Kashmakov et al. Oct 2007 A1
20070277832 Doshi Dec 2007 A1
20070283962 Doshi et al. Dec 2007 A1
20070295338 Loomas et al. Dec 2007 A1
20080173309 Doshi Jul 2008 A1
20080178874 Doshi et al. Jul 2008 A1
20080221470 Sather et al. Sep 2008 A1
20080275424 Doshi et al. Nov 2008 A1
20090011323 Guan et al. Jan 2009 A1
20090145441 Doshi et al. Jun 2009 A1
20090145788 Doshi et al. Jun 2009 A1
20090194100 Minagi Aug 2009 A1
20090194109 Doshi et al. Aug 2009 A1
20090308398 Ferdinand et al. Dec 2009 A1
20090308402 Robitaille Dec 2009 A1
20090320851 Selvarajan et al. Dec 2009 A1
20100031965 Soderberg Feb 2010 A1
20100147308 Doshi et al. Jun 2010 A1
20100234789 Batiste et al. Sep 2010 A1
20100234880 Abbott et al. Sep 2010 A1
20100331777 Danielsson Dec 2010 A1
20110005520 Doshi et al. Jan 2011 A1
20110005528 Doshi et al. Jan 2011 A1
20110005529 Doshi et al. Jan 2011 A1
20110005530 Doshi et al. Jan 2011 A1
20110218451 Lai et al. Sep 2011 A1
20120111340 Robitaille May 2012 A1
20130081637 Foley et al. Apr 2013 A1
Foreign Referenced Citations (28)
Number Date Country
1 157 663 Nov 2001 EP
1 917 993 May 2008 EP
2 210 109 Jul 1974 FR
2 610 830 Aug 1988 FR
2 126 101 Mar 1984 GB
2 176 406 Dec 1986 GB
2 324 729 Nov 1998 GB
WO 8705798 Oct 1987 WO
WO 9012614 Nov 1990 WO
WO 9517220 Jun 1995 WO
WO 9533520 Dec 1995 WO
WO 0029066 May 2000 WO
WO 0050121 Aug 2000 WO
WO 0067848 Nov 2000 WO
WO 0102042 Jan 2001 WO
WO 0113839 Mar 2001 WO
WO 0113908 Mar 2001 WO
WO 0149371 Jul 2001 WO
WO 0187170 Nov 2001 WO
WO 0238038 May 2002 WO
WO 2004060438 Jul 2004 WO
WO 2004060438 Jul 2004 WO
WO 2004069110 Aug 2004 WO
WO 2006063339 Jun 2006 WO
WO 2006063339 Jun 2006 WO
WO 2007023607 Mar 2007 WO
WO 2007129814 Nov 2007 WO
WO 2007134458 Nov 2007 WO
Non-Patent Literature Citations (6)
Entry
Extended European Search Report in European Application No. 07719844.8, dated Oct. 7, 2009, 7 pages.
Extended European Search Report for European Application No. 12152742.8, dated Jul. 18, 2012, 11 pages.
European Search Report for Application No. 12835151.7 dated Jan. 14, 2016 6 pages.
International Search Report in International Application No. PCT/CA2007/000922, dated Aug. 14, 2007, 2 pages.
International Preliminary Report on Patentability for International Application No. PCT/CA2007/000922, dated Nov. 27, 2008, 5 pages.
International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/IB2012/001929, dated Jan. 16, 2013, 10 pages.
Related Publications (1)
Number Date Country
20180008453 A1 Jan 2018 US
Provisional Applications (1)
Number Date Country
61540740 Sep 2011 US
Continuations (1)
Number Date Country
Parent 13629921 Sep 2012 US
Child 15655387 US